(Q35807013)

English

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients

scientific article published on 14 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

0 references

invasive pulmonary aspergillosis

1 reference

based on heuristic

inferred from title

Jean Paul Latgé

13

object named as

Jean Paul Latgé

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

18

object named as

Annie Sulahian

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Francis Derouin

16

object named as

Francis Derouin

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Anne Bergeron

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Raphaël Porcher

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Jean Menotti

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Jean Louis Poirot

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Karine Chagnon

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Anne Vekhoff

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Muriel Cornet

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Françoise Isnard

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Emmanuel Raffoux

9

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Benoit Brethon

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Claire Lacroix

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sophie Touratier

12

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Claire Bouges-Michel

14

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Abdellatif Tazi

15

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Patricia Ribaud

17

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

14 December 2011

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

50

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

823-830

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Newer combination antifungal therapies for invasive aspergillosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Changes in causes of death over time after treatment for invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Laboratory diagnosis of invasive aspergillosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

11 July 2018

Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Factors associated with overall and attributable mortality in invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3295141

25 September 2018

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant antigens as diagnostic markers for aspergillosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22170907

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.00750-11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35807013&oldid=1963475078"